
|Articles|July 11, 2012
Cost Implications of Pertuzumab/Trastuzumab Combination
In this segment, panelists address coverage strategies health plans may utilize to finance patient access to the combination treatment.
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Oral PCSK9 Inhibitor Enlicitide Matches Injectables in Lowering LDL Cholesterol
2
Improving Patient-Centered Cardiovascular Care for Older Adults
3
Introduction of Work Requirements to Medicaid Enrollment Could Destabilize Health: William Schpero, PhD, MPhil, MPH
4
Gefurulimab for MG Exhibits Lasting Efficacy, Safety in Topline PREVAIL Trial Data
5















































